{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:02:00Z","timestamp":1771002120727,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[1999,4,23]],"date-time":"1999-04-23T00:00:00Z","timestamp":924825600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.1038\/sj.bjc.6690437","type":"journal-article","created":{"date-parts":[[2002,9,17]],"date-time":"2002-09-17T14:24:08Z","timestamp":1032272648000},"page":"892-897","source":"Crossref","is-referenced-by-count":128,"title":["Platelet number and interleukin-6 correlate with VEGF but not with bFGF serum levels of advanced cancer patients"],"prefix":"10.1038","volume":"80","author":[{"given":"R","family":"Salgado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P B","family":"Vermeulen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Benoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Weytjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Huget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E Van","family":"Marck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Y","family":"Dirix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[1999,4,23]]},"reference":[{"key":"BF6690437_CR1","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/bjc.1998.158","volume":"77","author":"RE Banks","year":"1998","unstructured":"Banks, R. E., Forbes, M. A., Kinsey, S. E., Stanley, A., Ingham, E., Walters, C. & Selby, P. J. (1998). Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: significance for VEGF measurements and cancer biology. Br J Cancer 77: 956\u2013964.","journal-title":"Br J Cancer"},{"key":"BF6690437_CR2","first-page":"3317","volume":"52","author":"JY Blay","year":"1992","unstructured":"Blay, J. Y., Negrier, S., Combaret, V., Attali, S., Goillot, E., Merrouche, Y., Mercatello, A., Ravault, A., Tourani, J. M., Moskovtchenko, J. F. & Philip, T. (1992). Serum levels of interleukin 6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 52: 3317\u20133322.","journal-title":"Cancer Res"},{"key":"BF6690437_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1023\/A:1018882322566","volume":"42","author":"A Bousvaros","year":"1997","unstructured":"Bousvaros, A., Zurakowski, D., Fishman, S. J., Keough, K., Law, T., Sun, C. & Leichter, A. M. (1997). Serum basic fibroblast growth factor in pediatric Crohn\u2019s disease. Implications for wound healing. Dig Dis Sci 42: 378\u2013386.","journal-title":"Dig Dis Sci"},{"key":"BF6690437_CR4","first-page":"1952","volume":"58","author":"RA Brekken","year":"1998","unstructured":"Brekken, R. A., Huang, X., King, S. W. & Thorpe, P. E. (1998). Vascular endothelial growth factor as a marker of tumor endothelium. Cancer Res 58: 1952\u20131959.","journal-title":"Cancer Res"},{"key":"BF6690437_CR5","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1097\/00005176-199608000-00012","volume":"23","author":"DA Bross","year":"1996","unstructured":"Bross, D. A., Leichtner, A. M., Zurakowski, D., Law, T. & Bousvaros, A. (1996). Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn\u2019s disease. J Pediatr Gastroenterol Nutr 23: 164\u2013171.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"9","key":"BF6690437_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1006\/cyto.1996.0095","volume":"8","author":"Deborah Clarke","year":"1996","unstructured":"Clarke, D., Johnson, P. W. M., Banks, R. E., Storr, M., Kinsey, S. E., Johnson, R., Morgan, G., Gordon, M. Y., lllingworth, J. M., Perren, T. J. & Selby, P. J. (1996). Cytokine 8: 717\u2013723.","journal-title":"Cytokine"},{"key":"BF6690437_CR7","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1074\/jbc.271.2.736","volume":"271","author":"T Cohen","year":"1996","unstructured":"Cohen, T., Nahari, D., Weiss Cerem, L., Neufeld, G. & Levi, B. (1996). Interleukin 6 induces the expression of vascular endothelial growth factor. J Biol Chem 271: 736\u2013741.","journal-title":"J Biol Chem"},{"key":"BF6690437_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/(SICI)1097-0215(19961009)68:2<207::AID-IJC12>3.0.CO;2-7","volume":"68","author":"A Degeorges","year":"1996","unstructured":"Degeorges, A., Tatoud, R., Fauvel-Lafeve, F., Podgorniak, M-P, Millot, G., De Cremoux, P. & Calvo, F. (1996). Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer 68: 207\u2013214.","journal-title":"Int J Cancer"},{"key":"BF6690437_CR9","first-page":"2331","volume":"15","author":"S Duensig","year":"1995","unstructured":"Duensig, S., Grosse, J. & Atzpodien, J. (1995). Increased serum levels of basic fibroblast growth factor (bFGF) are associated with progressive lung metastases in advanced renal cell carcinoma patients. Anticancer Res 15: 2331\u20132334.","journal-title":"Anticancer Res"},{"key":"BF6690437_CR10","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak, H. F. (1986). Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med 315: 1650\u20131659.","journal-title":"N Engl J Med"},{"key":"BF6690437_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1093\/oxfordjournals.annonc.a010764","volume":"7","author":"LY Dirix","year":"1996","unstructured":"Dirix, L. Y., Vermeulen, P. B., Hubens, G., Benoy, I., Martin, M., De Pooter, C. & Van Oosterom, A. T. (1996). Serum basic fibroblast growth factor and vascular endothelial growth factor and tumour growth kinetics in advanced colorectal cancer. Ann Oncol 7: 843\u2013848.","journal-title":"Ann Oncol"},{"key":"BF6690437_CR12","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/bjc.1997.368","volume":"76","author":"LY Dirix","year":"1997","unstructured":"Dirix, L. Y., Vermeulen, P. B., Pawinski, A., Prov\u00e9, A., Benoy, I., De Pooter, C., Martin, M. & Van Oosterom, A. T. (1997). Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients. Br J Cancer 76: 238\u2013243.","journal-title":"Br J Cancer"},{"key":"BF6690437_CR13","first-page":"2451","volume":"3","author":"C Dosquet","year":"1997","unstructured":"Dosquet, C., Coudert, M-C, Lepage, E., Cabane, J. & Richard, F. (1997). Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?. Clin Cancer Res 3: 2451\u20132458.","journal-title":"Clin Cancer Res"},{"key":"BF6690437_CR14","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ajh.2830190107","volume":"19","author":"JP Ferriere","year":"1985","unstructured":"Ferriere, J. P., Bernard, D., Legros, M., Chassagne, J., Chollet, P., Gaillard, G. & Plagne, R. (1985). \u03b2-Thromboglobulin in patients with breast cancer. Am J Hematol 19: 47\u201353.","journal-title":"Am J Hematol"},{"key":"BF6690437_CR15","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/jnci\/82.1.4","volume":"82","author":"J Folkman","year":"1990","unstructured":"Folkman, J. (1990). What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82: 4\u20136.","journal-title":"J Natl Cancer Inst"},{"key":"BF6690437_CR16","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1016\/S0959-8049(96)00424-8","volume":"32A","author":"G Gasparini","year":"1996","unstructured":"Gasparini, G. (1996). Angiogenesis research up to 1996. A commentary on the state of art and suggestions for future studies. Eur J Cancer 32A: 2379\u20132385.","journal-title":"Eur J Cancer"},{"key":"BF6690437_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1172\/JCI114173","volume":"84","author":"PJ Handagama","year":"1987","unstructured":"Handagama, P. J., Shuman, M. A. & Bainston, D. F. (1987). Incorporation of intravenously injected albumin, immunoglobulin G, and fibrinogen in guinea pig megakaryocyte granules. J Clin Invest 84: 73\u201382.","journal-title":"J Clin Invest"},{"key":"BF6690437_CR18","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1172\/JCI114300","volume":"84","author":"P Harrison","year":"1989","unstructured":"Harrison, P., Wilbourn, B., Debili, N., Vainchenker, W., Breton-Gorius, J., Lawrie, A. S., Masse, J-M, Savidge, G. F. & Cramer, E. M. (1989). Uptake of plasma fibrogen into the alpha granules of human megakaryocytes and platelets. J Clin Invest 84: 1320\u20131324.","journal-title":"J Clin Invest"},{"key":"BF6690437_CR19","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1182\/blood.V74.4.1241.1241","volume":"74","author":"T Ishibashi","year":"1989","unstructured":"Ishibashi, T., Kimura, H., Shikama, Y., Uchida, T., Kariyone, S., Hirano, T., Kishimoto, T., Takatsuki, F. & Akiyama, Y. (1989). Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood 74: 1241\u20131244.","journal-title":"Blood"},{"key":"BF6690437_CR20","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1172\/JCI107470","volume":"52","author":"EA Jaffe","year":"1973","unstructured":"Jaffe, E. A., Nachman, R. L., Becker, C. G. & Minick, C. R. (1973). Culture of human endothelial cells derived from umbilical veins. J Clin Invest 52: 2745\u20132756.","journal-title":"J Clin Invest"},{"key":"BF6690437_CR21","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V86.2.419.bloodjournal862419","volume":"86","author":"K Kaushansky","year":"1995","unstructured":"Kaushansky, K. (1995). Thrombopoietin: the primary regulator of platelet production. Blood 86: 419\u2013431.","journal-title":"Blood"},{"key":"BF6690437_CR22","first-page":"1279","volume":"4","author":"H Kumar","year":"1998","unstructured":"Kumar, H., Heer, K., Lee, P. W. R., Duthie, G. S., MacDonald, A. W., Greenman, J., Kerin, M. J. & Monson, J. R. T. (1998). Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin Cancer Res 4: 1279\u20131285.","journal-title":"Clin Cancer Res"},{"key":"BF6690437_CR23","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1007\/BF01072463","volume":"23","author":"AM Lake","year":"1978","unstructured":"Lake, A. M., Stauffer, J. Q. & Stuart, M. J. (1978). Hemostatic alterations in inflammatory bowel disease: response to therapy. Am J Dig Dis 23: 897\u2013902.","journal-title":"Am J Dig Dis"},{"key":"BF6690437_CR24","first-page":"997","volume":"34","author":"LA Liotta","year":"1974","unstructured":"Liotta, L. A. & Saidel, G. M. (1974). Quantitative relationship of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Res 34: 997\u20131004.","journal-title":"Cancer Res"},{"key":"BF6690437_CR25","first-page":"R1840","volume":"266","author":"RB Mateo","year":"1994","unstructured":"Mateo, R. B., Reichner, J. S. & Albina, J. E. (1994). Interleukin-6 activity in wounds. Am J Physiol 266: R1840\u20131844.","journal-title":"Am J Physiol"},{"key":"BF6690437_CR26","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1136\/thx.43.12.978","volume":"43","author":"R Milroy","year":"1988","unstructured":"Milroy, R., Douglas, J. T., Campbell, J., Carter, R., Lowe, G. D. & Banham, S. W. (1988). Abnormal haemostasis in small cell lung cancer. Thorax 43: 978\u2013981.","journal-title":"Thorax"},{"key":"BF6690437_CR27","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1073\/pnas.94.2.663","volume":"94","author":"R M\u00f6hle","year":"1997","unstructured":"M\u00f6hle, R., Green, D., Moore, M. A. S., Nachman, R. L. & Rafii, S. (1997). Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci USA 94: 663\u2013668.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690437_CR28","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1183\/09031936.96.09091826","volume":"9","author":"LM M\u00f8ller Pedersen","year":"1996","unstructured":"M\u00f8ller Pedersen, L. M. & Milman, N. (1996). Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 9: 1826\u20131830.","journal-title":"Eur Respir J"},{"key":"BF6690437_CR29","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.1073\/pnas.87.8.3092","volume":"87","author":"B Motro","year":"1990","unstructured":"Motro, B., Itin, A., Sachs, L. & Keshet, E. (1990). Pattern of interleukin 6 gene expression in vivo suggests a role for this cytokine in angiogenesis. Proc Natl Acad Sci USA 87: 3092\u20133096.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF6690437_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/bjc.1998.150","volume":"77","author":"T Nakano","year":"1998","unstructured":"Nakano, T., Chaninian, A. P., Shinjo, M., Tonomura, A., Miyake, M., Togawa, N., Ninomiya, K. & Higashino, K. (1998). Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma. Br J Cancer 77: 907\u2013912.","journal-title":"Br J Cancer"},{"key":"BF6690437_CR31","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/jcp.1041590208","volume":"159","author":"JW Rak","year":"1994","unstructured":"Rak, J. W., Hegmann, E. J., Lu, C. & Kerbel, R. S. (1994). Progressive loss of sensitivity to endothelium-derived growth inhibitors expressed by human melanoma cells during disease progression. J Cell Physiol 159: 245\u2013255.","journal-title":"J Cell Physiol"},{"key":"BF6690437_CR32","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/S0959-8049(96)00396-6","volume":"32A","author":"J Rak","year":"1996","unstructured":"Rak, J., Filmus, J. & Kerbel, R. S. (1996). Reciprocal paracrine interactions between tumour cells and endothelial cells: \u2018angiogenesis progression\u2019 hypothesis. Eur J Cancer 32A: 2438\u20132450.","journal-title":"Eur J Cancer"},{"key":"BF6690437_CR33","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/S0140-6736(94)90387-5","volume":"344","author":"C Ravoet","year":"1994","unstructured":"Ravoet, C., De Gr\u00e8ve, J., Vandewoude, K., Kerger, J., Sculier, J-P, Lacor, P., Stryckmans, P. & Piccart, M. (1994). Tumour stimulating effects of recombinant human interleukin-6. Lancet 344: 1576\u20131577.","journal-title":"Lancet"},{"key":"BF6690437_CR34","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood.V90.8.3167","volume":"90","author":"P Salven","year":"1997","unstructured":"Salven, P., Teerenhovi, L. & Joensuu, H. (1997). A high pretreatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin\u2019s lymphoma. Blood 90: 3167\u20133172.","journal-title":"Blood"},{"key":"BF6690437_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/(SICI)1097-0215(19980417)79:2<144::AID-IJC8>3.0.CO;2-T","volume":"79","author":"P Salven","year":"1998","unstructured":"Salven, P., Ruotsalainen, Mattson, K. & Joensuu, H. (1998). High pretreatment serum level of vascular endothelial growth factor (VEGF) is associated with poor outcome in small cell lung cancer. Int J Cancer 79: 144\u2013146.","journal-title":"Int J Cancer"},{"key":"BF6690437_CR36","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/nm1197-1222","volume":"11","author":"M Skobe","year":"1997","unstructured":"Skobe, M., Rockwell, P., Goldstein, N., Vosseler, S. & Fusenig, N. E. (1997). Halting angiogenesis suppresses carcinoma cell invasion. Nat Med 11: 1222\u20131227.","journal-title":"Nat Med"},{"key":"BF6690437_CR37","doi-asserted-by":"publisher","first-page":"731","DOI":"10.7326\/0003-4819-126-9-199705010-00001","volume":"126","author":"S Vadhan-Raj","year":"1997","unstructured":"Vadhan-Raj, S., Murray, L. J., Bueso-Ramos, C., Patel, S., Reddy, S. P., Hoots, W. K., Johnston, T., Papadopoulos, N. E., Hittelman, W. N., Johnston, D. A., Yang, T. A., Paton, V. E., Cohen, R. L., Hellmann, S. D., Benjamin, R. S. & Broxmeyer, H. E. (1997). Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer. Ann Intern Med 126: 731\u20133.","journal-title":"Ann Intern Med"},{"key":"BF6690437_CR38","first-page":"2187","volume":"3","author":"HMW Verheul","year":"1997","unstructured":"Verheul, H. M. W., Hoekman, K., Luykx-de Bakker, S., Eekman, C. A., Folman, C. C., Broxterman, H. J. & Pinedo, H. M. (1997). Platelet: transporter of vascular endothelial growth factor. Clin Cancer Res 3: 2187\u20132190.","journal-title":"Clin Cancer Res"},{"key":"BF6690437_CR39","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1016\/S0959-8049(96)00379-6","volume":"32A","author":"PB Vermeulen","year":"1996","unstructured":"Vermeulen, P. B., Gasparini, G., Fox, S. B., Toi, M., Martin, L., McCulloch, P., Pezzella, F., Viale, G., Weidner, N., Harris, A. L. & Dirix, L. Y. (1996). Quantification of angiogenesis in solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 32A: 2474\u20132484.","journal-title":"Eur J Cancer"},{"key":"BF6690437_CR40","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1093\/jnci\/89.17.1316","volume":"89","author":"PB Vermeulen","year":"1997","unstructured":"Vermeulen, P. B., Dirix, L. Y., Martin, M., Lemmens, J. & Van Oosterom, A. T. (1997). The predictive value of serum bFGF and VEGF in patients with metastatic renal cell carcinoma treated with interferon \u03b1-2b. J Natl Cancer Inst 89: 1317","journal-title":"J Natl Cancer Inst"},{"key":"BF6690437_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-0037-1615158","volume":"80","author":"U Wartiovaara","year":"1998","unstructured":"Wartiovaara, U., Salven, P., Mikkola, H., Lassila, R., Kaukonen, J., Joukov, V., Orpana, A., Ristim\u00e4ki, A., Heikinheimo, M., Joensuu, H., Alitalo, K. & Palotie, A. (1998). Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb Haemost 80: 171\u2013175.","journal-title":"Thromb Haemost"},{"key":"BF6690437_CR42","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1200\/JCO.1993.11.3.499","volume":"11","author":"J Weber","year":"1993","unstructured":"Weber, J., Yang, J. C., Topalian, S. L., Parkinson, D. R., Schwartzentruber, D. S., Ettinghausen, S. E., Gunn, H., Mixon, A., Kim, H. & Cole, D. (1993). Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol 11: 499\u2013506.","journal-title":"J Clin Oncol"},{"key":"BF6690437_CR43","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/0090-4295(87)90574-7","volume":"30","author":"T Yazaki","year":"1987","unstructured":"Yazaki, T., Inage, H., Iizumi, T., Koyama, A., Kanoh, S., Koiso, K., Narita, M. & Tojo, S. (1987). Studies on platelet function in patients with prostatic cancer. Preliminary report. Urology 30: 60\u201363.","journal-title":"Urology"},{"key":"BF6690437_CR44","doi-asserted-by":"publisher","first-page":"11463","DOI":"10.1074\/jbc.270.19.11463","volume":"270","author":"SF Yan","year":"1995","unstructured":"Yan, S. F., Tritto, I., Pinsky, D., Liao, H., Huang J Fuller, G., Brett, J., May, L. & Stern, D. (1995). Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. J Biol Chem 270: 11463\u201311471.","journal-title":"J Biol Chem"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6690437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690437","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6690437.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:53:30Z","timestamp":1684414410000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6690437"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,4,23]]},"references-count":44,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["BF6690437"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6690437","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,4,23]]}}}